NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TechnoDerma Medicines Inc.

TechnoDerma Medicines Inc.

Private
ChengduHealthcare & Life Scienceshttp://tkskin.com/

Last Round

Series B

Jan 14, 2024

Company Overview

TechnoDerma Medicines Inc. is a clinical-stage biopharmaceutical company that develops innovative small molecule drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis, and lupus.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule drugsdermatologydrug discoverybiotechtopical treatmentclinical trialsJAK inhibitorautoimmune diseasedrug developmentpharma licensingclinical-stage biotechatopic dermatitisandrogenetic alopeciapsoriasis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TechnoDerma Medicines Inc. Comparables

Compare TechnoDerma Medicines Inc. with similar companies based on industry and business-model similarity.

TechnoDerma Medicines Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Veradermics Inc.
84%
Lynk Pharmaceuticals
83%
Amplifica Holdings Group, Inc.
81%

TechnoDerma Medicines Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 14, 2024
Series A ExtensionJan 13, 2023
Series AApr 14, 2021

TechnoDerma Medicines Inc. Investors

Notable investors and investment history

TechnoDerma Medicines Inc. investors
InvestorRounds
CDH InvestmentsSeries A
Zoo CapitalSeries B
Oceanpine CapitalSeries A
Viva BioInnovatorSeries A Extension, Series B, Series A, Accelerator
Chengdu Hi-tech Investment Group Co., Ltd.Series A Extension
CDH InvestmentsSeries A
Lingdao CapitalSeries A

TechnoDerma Medicines Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TechnoDerma Medicines Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TechnoDerma Medicines Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Year Founded2014
Last FundingJan 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.